Replies to post #4926 on ANI Pharmaceuticals (ANIP)

[Jeffqdh]

JTFM

With two patent pending s for libigel for CV

And the first proven safety study of its kind , there a very good possibility ANI is a BO candidate !

Especially now the pink pill is coming to market, libigel has a symbiotic relationship with Androgels developers

It's time to move it over to a large pharm that has the resources to monetize it in a way only they can. I would like to see the patents come through first. If your suspicion is correct , Abbvie plans on obtaining a expedited review for CV benefits it's going to be large BO #

GLTA

[Just the facts maam]

Correction, typo, should read $50 million not $60 million as total value of CVR commitment.